| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$162,251,771 |
|
|
|
Indirect Value
|
$375,195,594 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$537,447,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGEN |
Precigen Inc |
|
– • • |
2023-12-28 |
4 |
B |
$1.41 |
$136,327 |
I/I |
96,686 |
1,096,686 |
0.01 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-06 |
4 |
B |
$5.23 |
$909,717 |
I/I |
173,942 |
1,113,111 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-07 |
4 |
B |
$5.26 |
$779,727 |
I/I |
148,237 |
1,142,758 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-07 |
4 |
B |
$5.55 |
$1,865,910 |
I/I |
336,200 |
1,182,000 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-14 |
4 |
B |
$8.13 |
$1,788,600 |
I/I |
220,000 |
1,220,000 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2020-12-17 |
4 |
A |
$0.00 |
$0 |
I/I |
11,306,281 |
1,260,538 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-11 |
4 |
B |
$6.16 |
$492,800 |
I/I |
80,000 |
1,262,000 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$5.58 |
$4,154,573 |
I/I |
713,232 |
1,271,423 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$5.51 |
$157,845 |
I/I |
28,463 |
1,299,886 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2007-03-13 |
4 |
B |
$7.93 |
$365,414 |
I/I |
46,080 |
1,308,080 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-07-10 |
4 |
OE |
$1.75 |
$238,525 |
I/I |
136,300 |
1,436,186 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-15 |
4 |
B |
$8.18 |
$1,985,319 |
I/I |
242,704 |
1,462,704 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,460 |
1,620,946 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-16 |
4 |
B |
$8.19 |
$1,437,509 |
I/I |
175,520 |
1,638,224 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,334 |
1,639,280 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-21 |
4 |
B |
$8.04 |
$454,075 |
I/I |
56,477 |
1,694,701 |
2.25 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-22 |
4 |
B |
$8.11 |
$447,234 |
I/I |
55,146 |
1,749,847 |
2.25 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2013-01-25 |
4 |
B |
$0.00 |
$0 |
I/I |
6,000,000 |
1,849,181 |
1.42 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$18.02 |
$7,789,127 |
I/I |
(432,249) |
1,897,610 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-11-23 |
4 |
B |
$8.00 |
$1,328,800 |
I/I |
166,100 |
1,915,947 |
2.25 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$6,999,997 |
D/D |
424,178 |
2,063,458 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
508,617 |
2,091,141 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-27 |
4 |
S |
$18.22 |
$1,992,849 |
I/I |
(109,377) |
2,154,470 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2018-08-24 |
4 |
S |
$18.20 |
$1,881,370 |
I/I |
(103,372) |
2,219,466 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-07-17 |
4 |
B |
$22.00 |
$49,500,000 |
I/I |
2,250,000 |
2,250,000 |
2.25 |
- |
|
271 Records found
|
|
Page 6 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
